Crohn’s Disease Testing: the Complete 2026 Diagnostic Guide

Crohn’s disease testing involves multiple diagnostic procedures that identify inflammation patterns throughout your digestive tract. From initial blood work and fecal calprotectin screening to definitive colonoscopy and advanced imaging, proper testing determines disease severity and location essential factors that guide both conventional treatments and integrative approaches. Understanding these diagnostic methods empowers you to work effectively with your healthcare team while exploring all therapeutic options.

Quick Answer: What Tests Diagnose Crohn’s Disease

Reaching a Crohn’s diagnosis requires a systematic approach. Doctors rarely rely on a single test because symptoms can mimic other digestive disorders. Instead, they use a combination of laboratory work, imaging studies, and direct visualization procedures to build a complete picture of your digestive health.

Multiple tests are essential because Crohn’s can affect any part of your digestive tract from your mouth to your anus and the inflammation pattern varies significantly between patients. Some people have disease confined to the ileum, while others experience widespread inflammation. According to Cdc, approximately 0.5% of adults in the United States (around 1.3 million people) have been diagnosed with inflammatory bowel disease. This prevalence underscores why accurate testing matters for such a substantial patient population.

@keyframes hoox-lf-in-hoox-f-29a02d73-cfe7-4873-83ff-817dc5-top {
from { opacity: 0; transform: translateY(8px); }
to { opacity: 1; transform: translateY(0); }
}

#hoox-f-29a02d73-cfe7-4873-83ff-817dc5-top {
width: 100%;
max-width: 100%;
box-sizing: border-box;
display: flex;
flex-direction: column;
gap: 20px;
margin: 48px 0;
padding: 32px 28px;
border-radius: 16px;
background: #ffffff;
color: #111111;
font-family: inherit;
border: 1px solid #E2E8F0;
animation: hoox-lf-in-hoox-f-29a02d73-cfe7-4873-83ff-817dc5-top 0.3s cubic-bezier(0.16, 1, 0.3, 1);
direction: inherit;
}

#hoox-f-29a02d73-cfe7-4873-83ff-817dc5-top .hoox-form-header {
display: flex;
flex-direction: column;
gap: 8px;
text-align: center;
}

#hoox-f-29a02d73-cfe7-4873-83ff-817dc5-top .hoox-form-header h2 {
margin: 0;
font-size: 1.5em;
font-weight: 700;
line-height: 1.3;
color: #111111;
border: none;
padding: 0;
}

#hoox-f-29a02d73-cfe7-4873-83ff-817dc5-top .hoox-form-header p {
margin: 0;
font-size: 1em;
line-height: 1.6;
color: #64748B;
}

#hoox-f-29a02d73-cfe7-4873-83ff-817dc5-top form[data-hx-form] {
margin: 0;
display: flex;
flex-direction: column;
gap: 14px;
}

#hoox-f-29a02d73-cfe7-4873-83ff-817dc5-top .hoox-field-wrap {
position: relative;
width: 100%;
box-sizing: border-box;
}

#hoox-f-29a02d73-cfe7-4873-83ff-817dc5-top .hoox-field-wrap input {
width: 100%;
box-sizing: border-box;
height: 44px;
padding-inline-start: 42px;
padding-inline-end: 14px;
border: 1px solid #E2E8F0;
border-radius: 10px;
font-size: 14px;
color: #111111;
font-family: inherit;
background-color: #F8FAFC;
transition: border-color 0.15s ease, box-shadow 0.15s ease, background-color 0.15s ease;
outline: none;
direction: inherit;
text-align: start;
}

#hoox-f-29a02d73-cfe7-4873-83ff-817dc5-top .hoox-field-wrap input::placeholder {
color: #94A3B8;
opacity: 1;
}

#hoox-f-29a02d73-cfe7-4873-83ff-817dc5-top .hoox-field-wrap input:focus {
background-color: #FFFFFF;
border-color: #0077B6,#00B4D8,#90E0EF;
box-shadow: 0 0 0 3px rgba(15, 23, 42, 0.08);
}

#hoox-f-29a02d73-cfe7-4873-83ff-817dc5-top .hoox-field-icon {
position: absolute;
top: 0;
bottom: 0;
inset-inline-start: 0;
width: 42px;
display: flex;
align-items: center;
justify-content: center;
pointer-events: none;
color: #94A3B8;
transition: color 0.15s ease;
}

#hoox-f-29a02d73-cfe7-4873-83ff-817dc5-top .hoox-field-wrap:focus-within .hoox-field-icon {
color: #0077B6,#00B4D8,#90E0EF;
}

#hoox-f-29a02d73-cfe7-4873-83ff-817dc5-top button[type=”submit”] {
width: 100%;
height: 44px;
margin-top: 4px;
border: none;
border-radius: 10px;
background: #0077B6,#00B4D8,#90E0EF;
color: #FFFFFF;
font-size: 14px;
font-weight: 600;
cursor: pointer;
transition: opacity 0.15s ease, transform 0.15s ease, box-shadow 0.15s ease;
box-shadow: 0 1px 2px 0 rgba(0, 0, 0, 0.05);
}

#hoox-f-29a02d73-cfe7-4873-83ff-817dc5-top button[type=”submit”]:hover {
opacity: 0.94;
}

#hoox-f-29a02d73-cfe7-4873-83ff-817dc5-top button[type=”submit”]:active {
transform: scale(0.99);
}

#hoox-f-29a02d73-cfe7-4873-83ff-817dc5-top button[type=”submit”]:disabled {
opacity: 0.6;
cursor: not-allowed;
}

#hoox-f-29a02d73-cfe7-4873-83ff-817dc5-top .hoox-disclaimer {
margin: 0;
text-align: center;
font-size: 12px;
line-height: 1.5;
color: #94A3B8;
}

#hoox-f-29a02d73-cfe7-4873-83ff-817dc5-top .hoox-disclaimer a {
color: inherit;
text-decoration: underline;
text-underline-offset: 2px;
}

#hoox-f-29a02d73-cfe7-4873-83ff-817dc5-top .hoox-disclaimer a:hover {
text-decoration: none;
}

#hoox-f-29a02d73-cfe7-4873-83ff-817dc5-top .hoox-success {
display: none;
flex-direction: column;
align-items: center;
gap: 14px;
padding: 12px 0;
position: relative;
}

#hoox-f-29a02d73-cfe7-4873-83ff-817dc5-top .hoox-confetti {
position: absolute;
inset: 0;
overflow: visible;
pointer-events: none;
}

#hoox-f-29a02d73-cfe7-4873-83ff-817dc5-top .hoox-confetti span {
position: absolute;
top: 50%;
left: 50%;
width: 7px;
height: 11px;
background: var(–hoox-c);
border-radius: 2px;
opacity: 0;
animation: hoox-confetti-burst 0.9s ease-out forwards;
animation-delay: var(–hoox-d, 0s);
}

@keyframes hoox-confetti-burst {
0% { opacity: 1; transform: translate(-50%, -50%) rotate(0deg) scale(1); }
100% { opacity: 0; transform: translate(calc(-50% + var(–hoox-tx)), calc(-50% + var(–hoox-ty))) rotate(var(–hoox-rz)) scale(0.5); }
}

#hoox-f-29a02d73-cfe7-4873-83ff-817dc5-top .hoox-success-icon {
width: 52px;
height: 52px;
border-radius: 50%;
background: #ECFDF5;
display: flex;
align-items: center;
justify-content: center;
font-size: 26px;
line-height: 1;
animation: hoox-success-pop 0.4s cubic-bezier(0.34, 1.56, 0.64, 1);
}

@keyframes hoox-success-pop {
from { opacity: 0; transform: scale(0.5); }
to { opacity: 1; transform: scale(1); }
}

#hoox-f-29a02d73-cfe7-4873-83ff-817dc5-top .hoox-success-text {
margin: 0;
text-align: center;
font-size: 15px;
font-weight: 600;
line-height: 1.5;
color: #111111;
}

#hoox-f-29a02d73-cfe7-4873-83ff-817dc5-top .hoox-disabled-state {
display: none;
flex-direction: column;
align-items: center;
gap: 14px;
padding: 12px 0;
text-align: center;
}

#hoox-f-29a02d73-cfe7-4873-83ff-817dc5-top .hoox-disabled-icon {
width: 52px;
height: 52px;
border-radius: 50%;
background: #F1F5F9;
display: flex;
align-items: center;
justify-content: center;
color: #64748B;
}

#hoox-f-29a02d73-cfe7-4873-83ff-817dc5-top .hoox-disabled-text {
margin: 0;
font-size: 14px;
line-height: 1.6;
color: #64748B;
}

#hoox-f-29a02d73-cfe7-4873-83ff-817dc5-top .hoox-disabled-text a {
color: inherit;
font-weight: 600;
text-decoration: underline;
text-underline-offset: 2px;
}

#hoox-f-29a02d73-cfe7-4873-83ff-817dc5-top .hoox-disabled-text a:hover {
text-decoration: none;
}

The diagnostic journey typically follows a logical progression from non-invasive screening to more definitive procedures. For those wanting to understand the broader context of their diagnosis, common questions about IBD diagnosis can provide additional clarity.

• Blood tests Screen for inflammation markers, anemia, and nutrient deficiencies that suggest active disease
• Fecal calprotectin test Non-invasive stool test measuring intestinal inflammation levels
• Colonoscopy Direct visualization of the colon and terminal ileum with tissue sampling
• Upper endoscopy Examines esophagus, stomach, and duodenum for upper digestive tract involvement
• Advanced imaging (CT/MRI) Detailed cross-sectional views of small bowel and complications

Blood Tests Reveal Inflammation Markers in 2026

Blood work serves as your first diagnostic checkpoint. These tests don’t confirm Crohn’s on their own, but they reveal critical clues about what’s happening inside your body. Elevated inflammatory markers tell doctors something is wrong, prompting them to investigate further with more specific testing.

The C-reactive protein (CRP) test measures a protein your liver produces when inflammation is present. CRP rises quickly during active inflammation and falls when inflammation subsides, making it useful for monitoring disease activity. However, CRP can elevate for many reasons infections, injuries, or other inflammatory conditions so doctors interpret results alongside other findings.

Erythrocyte sedimentation rate (ESR), sometimes called “sed rate,” measures how quickly red blood cells settle at the bottom of a test tube. Inflammatory proteins cause cells to clump together and settle faster. ESR changes more slowly than CRP, providing a different window into inflammation patterns over time.

A complete blood count (CBC) reveals anemia, which affects many Crohn’s patients. Bleeding from intestinal inflammation depletes iron stores, while chronic disease suppresses red blood cell production. White blood cell counts may also elevate during active inflammation or infection. According to Nih, inflammatory bowel disease affects approximately 1.3 million Americans, and anemia remains one of the most common complications among this population.

Antibody tests like ASCA (anti-Saccharomyces cerevisiae antibodies) and pANCA (perinuclear anti-neutrophil cytoplasmic antibodies) help differentiate between Crohn’s disease and ulcerative colitis. While not definitive, these markers provide supporting evidence when other test results are ambiguous.

Understanding your blood work helps you track how well treatments work. Many patients combine conventional monitoring with natural supplements for IBD management to support their overall inflammatory response.

Test Type	What It Measures	Normal Range	Elevatedindications
CRP (C-reactive protein)	Acute inflammation protein	Less than 10 mg/L	Active inflammation, infection, tissue damage
ESR (Sed rate)	Inflammation over time	0-20 mm/hr (varies by age/sex)	Chronic inflammation, autoimmune activity
CBC (Complete blood count)	Red/white blood cells, hemoglobin	Hgb: 12-17.5 g/dL	Anemia, infection, nutrient deficiency
ASCA antibodies	Anti-yeast antibodies	Negative	Associated with Crohn’s disease
Ferritin/Iron	Iron storage levels	20-300 ng/mL	Iron deficiency anemia from bleeding

Fecal Calprotectin: The Non-Invasive Screening Breakthrough

Fecal calprotectin testing has transformed how doctors approach Crohn’s disease testing. This simple stool test measures calprotectin, a protein released by white blood cells when your intestines are inflamed. Elevated levels strongly suggest intestinal inflammation, helping doctors decide whether more invasive procedures are necessary.

Calprotectin offers something blood tests cannot direct evidence of gut inflammation. Blood markers like CRP can elevate for countless reasons, but calprotectin specifically indicates inflammatory activity within your digestive tract. This precision makes it invaluable for distinguishing between inflammatory bowel disease and irritable bowel syndrome, which produces similar symptoms but involves no inflammation.

According to Aafp, fecal calprotectin testing has emerged as a useful non-invasive tool to help determine whether ileocolonoscopy and imaging are needed in uncertain cases. This means some patients can avoid unnecessary procedures when calprotectin levels are normal, while elevated results prompt appropriate further investigation.

Doctors typically recommend calprotectin testing when symptoms are ambiguous or when monitoring known IBD patients for disease flares. Rising calprotectin levels often precede symptom flares, giving patients and doctors early warning to adjust treatment. For those exploring comprehensive approaches to managing inflammation, herbal approaches to reducing inflammation may offer complementary support.

Sample collection is straightforward you’ll receive a specialized container and instructions for collecting a small stool sample at home. Results typically arrive within a few days, and your doctor interprets them alongside your clinical picture.

How Colonoscopy and Endoscopy Confirm Crohn’s Location

Colonoscopy remains the gold standard for Crohn’s disease testing. This procedure allows doctors to directly visualize your colon and the terminal ileum the last portion of your small intestine where Crohn’s commonly develops. During colonoscopy, your gastroenterologist can identify characteristic findings like patchy inflammation, deep ulcers, and strictures that distinguish Crohn’s from other conditions.

The key advantage of colonoscopy lies in biopsy capability. Your doctor takes small tissue samples from inflamed and normal-appearing areas, which a pathologist examines under a microscope. Histological confirmation seeing specific cellular changes provides definitive diagnosis that no blood test or imaging study can match.

Upper endoscopy examines your esophagus, stomach, and duodenum through a flexible tube passed through your mouth. While Crohn’s most commonly affects the lower digestive tract, approximately 10-30% of patients have upper gastrointestinal involvement. Symptoms like nausea, vomiting, upper abdominal pain, or difficulty swallowing may prompt upper endoscopy even when colonoscopy appears normal.

Preparation is the part most patients dread, but modern protocols have improved significantly. Here’s what to expect:

• Dietary restrictions begin 1-3 days before typically clear liquids only, avoiding red or purple dyes
• Bowel prep solution causes diarrhea to clear your colon stay near a bathroom
• Hydration matters drink approved clear liquids to prevent dehydration and help prep work effectively
• Arrange transportation sedation means you cannot drive for 24 hours after the procedure
• Plan for recovery most people resume normal activities the next day
• Discuss biopsy results your doctor will schedule a follow-up to discuss tissue findings

Understanding what doctors find during endoscopy helps you appreciate why accurate diagnosis matters. If you’re curious about others’ experiences with the diagnostic journey, real patient experiences with IBD offers valuable perspective.

Advanced Imaging: CT, MRI, and Capsule Endoscopy

When Crohn’s affects areas beyond colonoscopy’s reach, advanced imaging technologies step in. These modalities evaluate the small bowel a 20-foot structure that standard endoscopy cannot fully access. Understanding each option helps you discuss appropriate testing with your healthcare team.

CT enterography combines computed tomography with contrast liquid that highlights your intestines. The scan produces detailed cross-sectional images showing bowel wall thickening, inflammation, abscesses, and fistulas. CT excels at detecting complications and provides rapid results, but involves radiation exposure that limits repeated use.

MR enterography uses magnetic resonance imaging instead of radiation, making it safer for patients requiring multiple scans over time. MRI superbly visualizes soft tissue and detects active inflammation through specialized sequences. The trade-off involves longer scan times and potential claustrophobia inside the MRI machine.

Capsule endoscopy involves swallowing a pill-sized camera that transmits thousands of images as it travels through your digestive tract. This technology visualizes the entire small bowel, detecting lesions colonoscopy and standard imaging might miss. However, capsule endoscopy cannot take biopsies, and if a stricture is suspected, doctors must confirm the capsule won’t become stuck.

According to Gi, advanced therapeutic approaches, including early intervention with biologic therapies, are now being considered instead of delayed step-up treatment for moderate-to-severe disease. This shift toward aggressive early treatment makes accurate imaging essential for proper disease staging.

For patients interested in how diagnostic advances connect to treatment evolution, understanding IBD treatment evolution provides helpful context.

Imaging Type	Best For	Pros	Cons
CT Enterography	Complications, abscesses, acute settings	Fast, detailed, widely available	Radiation exposure, contrast allergy risk
MR Enterography	Repeated monitoring, young patients	No radiation, excellent soft tissue detail	Longer scan, claustrophobia, less available
Capsule Endoscopy	Small bowel lesions, obscure bleeding	Visualizes entire small bowel, non-invasive	Cannot biopsy, capsule retention risk

What Your Test Results Mean for Treatment Options

Your diagnostic tests do more than confirm disease they reveal where inflammation exists, how severely your digestive tract is affected, and whether complications are present. This information directly shapes treatment recommendations, from mild cases requiring minimal intervention to severe disease demanding aggressive therapy.

Doctors classify Crohn’s disease using multiple factors: location (ileal, colonic, ileocolonic, or upper GI), behavior (inflammatory, stricturing, or penetrating), and severity (mild, moderate, severe). Each classification carries different prognostic implications and treatment approaches.

Mild to moderate disease typically begins with milder medications anti-inflammatories like mesalamine or corticosteroids for flares. Moderate to severe disease often requires immunomodulators or biologic therapies that target specific inflammatory pathways. Severe, aggressive disease may need combination therapy or surgery if complications like strictures, fistulas, or abscesses develop.

Understanding your disease classification empowers you to participate meaningfully in treatment decisions. Many patients find that combining conventional medical care with integrative IBD solutions provides comprehensive support for their digestive health journey.

• Remission No active inflammation; maintenance therapy prevents flares
• Mild disease Limited inflammation, normal daily activities; often managed with milder medications
• Moderate disease More extensive inflammation affecting daily life; typically requires immunomodulators
• Severe disease Significant inflammation, weight loss, complications; often needs biologic therapy
• Refractory disease No response to standard treatments; may require advanced therapies or surgery

Key Takeaways: Making Testing Work for Your Health Journey

Navigating Crohn’s disease testing feels overwhelming, but understanding the process transforms you from passive patient to active participant. Each test provides puzzle pieces that, assembled together, reveal your complete clinical picture. This knowledge empowers informed decisions about treatment approaches whether conventional, integrative, or combined.

Remember that diagnostic testing isn’t a one-time event. Crohn’s disease evolves over time, and regular monitoring catches changes early when interventions work best. Building a collaborative relationship with your gastroenterologist, asking questions about your results, and understanding what each finding means gives you control over your health journey.

For those ready to explore comprehensive approaches beyond conventional treatment, explore natural IBD management options offers additional pathways to consider.

• Multiple tests are essential No single test confirms Crohn’s; diagnosis requires blood work, stool tests, imaging, and endoscopy together
• Non-invasive screening advances Fecal calprotectin provides valuable inflammation data without invasive procedures
• Colonoscopy remains diagnostic gold standard Direct visualization plus biopsy provides definitive diagnosis
• Imaging reveals what endoscopy cannot CT, MRI, and capsule endoscopy evaluate small bowel disease extent
• Results guide treatment intensity Disease severity and location determine appropriate therapeutic approaches
• Advocacy matters Understanding your tests empowers meaningful participation in treatment decisions

FAQ: Common Questions About Crohn’s Disease Testing

How long does Crohn’s disease testing take?

Most diagnostic workups take 2-4 weeks. Blood tests return within days, fecal calprotectin within a week, but scheduling colonoscopy or imaging often takes longer. The timeline depends on your symptoms’ urgency and specialist availability. Emergency situations receive faster scheduling, while routine evaluations may wait longer.

Will I need to fast before Crohn’s testing?

Yes, for certain procedures. Blood tests require no preparation, but colonoscopy demands clear-liquid diets and bowel prep 1-3 days beforehand. Upper endoscopy requires fasting for 8+ hours before sedation. Your doctor provides specific instructions for each scheduled test.

How accurate are blood tests for detecting Crohn’s?

Blood tests alone cannot diagnose Crohn’s. They indicate inflammation or anemia but cannot confirm inflammatory bowel disease versus other conditions. Elevated CRP or ESR suggests inflammation; positive ASCA antibodies support Crohn’s diagnosis. However, definitive diagnosis requires endoscopy with biopsy showing characteristic tissue changes.

Is fecal calprotectin testing covered by insurance?

Most insurance plans cover calprotectin when medically necessary. Coverage varies by plan and clinical indication doctors must document why testing is appropriate. Out-of-pocket costs range from $50-200 without coverage. This test provides valuable information at relatively low cost compared to invasive alternatives.

How often should I repeat Crohn’s disease testing?

Monitoring frequency depends on disease activity. Active disease may require blood work every few months, while remission typically means annual check-ups. Colonoscopy surveillance usually occurs every 1-3 years, more frequently if dysplasia risk exists. Your gastroenterologist individualizes monitoring based on your specific situation.

Can Crohn’s be diagnosed without colonoscopy?

No colonoscopy with biopsy remains essential for definitive diagnosis. Blood tests and imaging can suggest Crohn’s but cannot replace direct tissue examination. In rare cases where colonoscopy is impossible, capsule endoscopy or imaging may provide sufficient evidence, but biopsy confirmation is preferred whenever possible. For additional IBD questions answered, our resource library offers more detailed information.

@keyframes hoox-lf-in-hoox-f-29a02d73-cfe7-4873-83ff-817dc5-bottom {
from { opacity: 0; transform: translateY(8px); }
to { opacity: 1; transform: translateY(0); }
}

#hoox-f-29a02d73-cfe7-4873-83ff-817dc5-bottom {
width: 100%;
max-width: 100%;
box-sizing: border-box;
display: flex;
flex-direction: column;
gap: 20px;
margin: 48px 0;
padding: 32px 28px;
border-radius: 16px;
background: #ffffff;
color: #111111;
font-family: inherit;
border: 1px solid #E2E8F0;
animation: hoox-lf-in-hoox-f-29a02d73-cfe7-4873-83ff-817dc5-bottom 0.3s cubic-bezier(0.16, 1, 0.3, 1);
direction: inherit;
}

#hoox-f-29a02d73-cfe7-4873-83ff-817dc5-bottom .hoox-form-header {
display: flex;
flex-direction: column;
gap: 8px;
text-align: center;
}

#hoox-f-29a02d73-cfe7-4873-83ff-817dc5-bottom .hoox-form-header h2 {
margin: 0;
font-size: 1.5em;
font-weight: 700;
line-height: 1.3;
color: #111111;
border: none;
padding: 0;
}

#hoox-f-29a02d73-cfe7-4873-83ff-817dc5-bottom .hoox-form-header p {
margin: 0;
font-size: 1em;
line-height: 1.6;
color: #64748B;
}

#hoox-f-29a02d73-cfe7-4873-83ff-817dc5-bottom form[data-hx-form] {
margin: 0;
display: flex;
flex-direction: column;
gap: 14px;
}

#hoox-f-29a02d73-cfe7-4873-83ff-817dc5-bottom .hoox-field-wrap {
position: relative;
width: 100%;
box-sizing: border-box;
}

#hoox-f-29a02d73-cfe7-4873-83ff-817dc5-bottom .hoox-field-wrap input {
width: 100%;
box-sizing: border-box;
height: 44px;
padding-inline-start: 42px;
padding-inline-end: 14px;
border: 1px solid #E2E8F0;
border-radius: 10px;
font-size: 14px;
color: #111111;
font-family: inherit;
background-color: #F8FAFC;
transition: border-color 0.15s ease, box-shadow 0.15s ease, background-color 0.15s ease;
outline: none;
direction: inherit;
text-align: start;
}

#hoox-f-29a02d73-cfe7-4873-83ff-817dc5-bottom .hoox-field-wrap input::placeholder {
color: #94A3B8;
opacity: 1;
}

#hoox-f-29a02d73-cfe7-4873-83ff-817dc5-bottom .hoox-field-wrap input:focus {
background-color: #FFFFFF;
border-color: #0077B6,#00B4D8,#90E0EF;
box-shadow: 0 0 0 3px rgba(15, 23, 42, 0.08);
}

#hoox-f-29a02d73-cfe7-4873-83ff-817dc5-bottom .hoox-field-icon {
position: absolute;
top: 0;
bottom: 0;
inset-inline-start: 0;
width: 42px;
display: flex;
align-items: center;
justify-content: center;
pointer-events: none;
color: #94A3B8;
transition: color 0.15s ease;
}

#hoox-f-29a02d73-cfe7-4873-83ff-817dc5-bottom .hoox-field-wrap:focus-within .hoox-field-icon {
color: #0077B6,#00B4D8,#90E0EF;
}

#hoox-f-29a02d73-cfe7-4873-83ff-817dc5-bottom button[type=”submit”] {
width: 100%;
height: 44px;
margin-top: 4px;
border: none;
border-radius: 10px;
background: #0077B6,#00B4D8,#90E0EF;
color: #FFFFFF;
font-size: 14px;
font-weight: 600;
cursor: pointer;
transition: opacity 0.15s ease, transform 0.15s ease, box-shadow 0.15s ease;
box-shadow: 0 1px 2px 0 rgba(0, 0, 0, 0.05);
}

#hoox-f-29a02d73-cfe7-4873-83ff-817dc5-bottom button[type=”submit”]:hover {
opacity: 0.94;
}

#hoox-f-29a02d73-cfe7-4873-83ff-817dc5-bottom button[type=”submit”]:active {
transform: scale(0.99);
}

#hoox-f-29a02d73-cfe7-4873-83ff-817dc5-bottom button[type=”submit”]:disabled {
opacity: 0.6;
cursor: not-allowed;
}

#hoox-f-29a02d73-cfe7-4873-83ff-817dc5-bottom .hoox-disclaimer {
margin: 0;
text-align: center;
font-size: 12px;
line-height: 1.5;
color: #94A3B8;
}

#hoox-f-29a02d73-cfe7-4873-83ff-817dc5-bottom .hoox-disclaimer a {
color: inherit;
text-decoration: underline;
text-underline-offset: 2px;
}

#hoox-f-29a02d73-cfe7-4873-83ff-817dc5-bottom .hoox-disclaimer a:hover {
text-decoration: none;
}

#hoox-f-29a02d73-cfe7-4873-83ff-817dc5-bottom .hoox-success {
display: none;
flex-direction: column;
align-items: center;
gap: 14px;
padding: 12px 0;
position: relative;
}

#hoox-f-29a02d73-cfe7-4873-83ff-817dc5-bottom .hoox-confetti {
position: absolute;
inset: 0;
overflow: visible;
pointer-events: none;
}

#hoox-f-29a02d73-cfe7-4873-83ff-817dc5-bottom .hoox-confetti span {
position: absolute;
top: 50%;
left: 50%;
width: 7px;
height: 11px;
background: var(–hoox-c);
border-radius: 2px;
opacity: 0;
animation: hoox-confetti-burst 0.9s ease-out forwards;
animation-delay: var(–hoox-d, 0s);
}

@keyframes hoox-confetti-burst {
0% { opacity: 1; transform: translate(-50%, -50%) rotate(0deg) scale(1); }
100% { opacity: 0; transform: translate(calc(-50% + var(–hoox-tx)), calc(-50% + var(–hoox-ty))) rotate(var(–hoox-rz)) scale(0.5); }
}

#hoox-f-29a02d73-cfe7-4873-83ff-817dc5-bottom .hoox-success-icon {
width: 52px;
height: 52px;
border-radius: 50%;
background: #ECFDF5;
display: flex;
align-items: center;
justify-content: center;
font-size: 26px;
line-height: 1;
animation: hoox-success-pop 0.4s cubic-bezier(0.34, 1.56, 0.64, 1);
}

@keyframes hoox-success-pop {
from { opacity: 0; transform: scale(0.5); }
to { opacity: 1; transform: scale(1); }
}

#hoox-f-29a02d73-cfe7-4873-83ff-817dc5-bottom .hoox-success-text {
margin: 0;
text-align: center;
font-size: 15px;
font-weight: 600;
line-height: 1.5;
color: #111111;
}

#hoox-f-29a02d73-cfe7-4873-83ff-817dc5-bottom .hoox-disabled-state {
display: none;
flex-direction: column;
align-items: center;
gap: 14px;
padding: 12px 0;
text-align: center;
}

#hoox-f-29a02d73-cfe7-4873-83ff-817dc5-bottom .hoox-disabled-icon {
width: 52px;
height: 52px;
border-radius: 50%;
background: #F1F5F9;
display: flex;
align-items: center;
justify-content: center;
color: #64748B;
}

#hoox-f-29a02d73-cfe7-4873-83ff-817dc5-bottom .hoox-disabled-text {
margin: 0;
font-size: 14px;
line-height: 1.6;
color: #64748B;
}

#hoox-f-29a02d73-cfe7-4873-83ff-817dc5-bottom .hoox-disabled-text a {
color: inherit;
font-weight: 600;
text-decoration: underline;
text-underline-offset: 2px;
}

#hoox-f-29a02d73-cfe7-4873-83ff-817dc5-bottom .hoox-disabled-text a:hover {
text-decoration: none;
}